Buck Wealth Strategies’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
Buck Wealth Strategies's BMY Position: Q2 2026 in Review
Buck Wealth Strategies opened a new position in Bristol-Myers Squibb (BMY) in Q2 2026: 1,107 shares worth $63.8K. The stake represents 0.01% of the portfolio and ranks #321 among its holdings. This is a return to the name: Buck Wealth Strategies previously reported a position in BMY as recently as Q3 2025.
Buck Wealth Strategies first reported a position in BMY in Q2 2025 and has held it in 3 quarters since. The position peaked at $949K in Q2 2025. 2,508 funds tracked by Wall St. Rank hold BMY as of Q2 2026.
- Buck Wealth Strategies held 1,107 shares of Bristol-Myers Squibb worth $63.8K as of Q2 2026.
- Bristol-Myers Squibb was a new Buck Wealth Strategies position in Q2 2026.
- Bristol-Myers Squibb made up 0.01% of Buck Wealth Strategies's portfolio in Q2 2026, its #321 holding.
- Buck Wealth Strategies first reported a position in Bristol-Myers Squibb in Q2 2025 and has held it in 3 quarters since.
- Buck Wealth Strategies's Bristol-Myers Squibb position peaked at $949K in Q2 2025.
- 2,508 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.
Based on Buck Wealth Strategies's 13F filing for Q2 2026, filed 30 Jul 2026.